JAGX logo

Jaguar Health, Inc.

JAGX
Healthcare|Biotechnology|US
$0.40
-0.00 (-0.69%)
Cash / Share
$122.17
Next Earnings Report
Nov 12, 2026
EPS est. -$444.29 · Revenue est. $4.8M
Financing Filings (last 12 months)
11
Shelf registrations / offering prospectuses — latest Nov 3, 2026 (S-3/A). Possible dilution.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Recent Press Releases

Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Oct 21, 2026 · Accesswire
Jaguar Health Provides Update Regarding Special Stock Dividend
Oct 14, 2026 · Accesswire
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Oct 14, 2026 · Accesswire
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Oct 13, 2026 · Accesswire
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Oct 6, 2026 · Accesswire
Jaguar Health Announces a Special Stock Dividend
Oct 2, 2026 · Accesswire
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of Gastroenterology Meeting
Sep 29, 2026 · Accesswire
Jaguar Health Receives Fee Waivers from FDA
Sep 22, 2026 · Accesswire
Jaguar Health, Inc. Announces Reverse Stock Split
Sep 15, 2026 · Accesswire
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Sep 10, 2026 · Accesswire

SEC Filings (161)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20268-KMaterial eventDocumentIndex
Nov 5, 2026EFFECTDocumentIndex
Nov 3, 2026S-3/AShelf registrationDocumentIndex
Nov 3, 20268-KMaterial eventDocumentIndex
Oct 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Oct 28, 20268-KMaterial eventDocumentIndex
Oct 22, 2026S-3Shelf registrationDocumentIndex
Oct 8, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 5, 20268-KMaterial eventDocumentIndex
Sep 29, 2026PRER14ADocumentIndex
Sep 28, 20268-KMaterial eventDocumentIndex
Sep 25, 20268-KMaterial eventDocumentIndex
Sep 24, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Sep 24, 2026424B5Offering prospectusDocumentIndex
Sep 24, 20268-KMaterial eventDocumentIndex
Sep 21, 20268-KMaterial eventDocumentIndex
Sep 18, 2026PRE 14AProxy / shareholder voteDocumentIndex
Sep 15, 20268-KMaterial eventDocumentIndex
Sep 15, 20268-KMaterial eventDocumentIndex
Sep 4, 20268-KMaterial eventDocumentIndex
Sep 3, 2026424B5Offering prospectusDocumentIndex
Aug 21, 2026424B3Offering prospectusDocumentIndex
Aug 19, 20268-KMaterial eventDocumentIndex
Aug 19, 202610-QQuarterly reportDocumentIndex
Aug 14, 2026EFFECTDocumentIndex
Aug 14, 2026NT 10-QDocumentIndex
Aug 11, 2026POS AMDocumentIndex
Aug 3, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 27, 2026424B3Offering prospectusDocumentIndex
Jul 27, 2026424B3Offering prospectusDocumentIndex
Jul 24, 2026EFFECTDocumentIndex
Jul 24, 2026EFFECTDocumentIndex
Jul 24, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jul 24, 2026S-1/AIPO / offering registrationDocumentIndex
Jul 16, 2026S-1IPO / offering registrationDocumentIndex
Jul 16, 2026S-1IPO / offering registrationDocumentIndex
Jul 14, 20268-KMaterial eventDocumentIndex
Jul 1, 20268-KMaterial eventDocumentIndex
Jul 1, 2026DDocumentIndex
Jul 1, 2026DDocumentIndex